Henan Taloph Pharmaceutical Stock Co Ltd

SSE:600222

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Henan Taloph Pharmaceutical Stock Co Ltd's stock price target?

Not Available

Henan Taloph Pharmaceutical Stock Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Henan Taloph Pharmaceutical Stock Co Ltd's Revenue forecast?

Projected CAGR

-3%

For the last 13 years the compound annual growth rate for Henan Taloph Pharmaceutical Stock Co Ltd's revenue is 5%. The projected CAGR for the next 10 years is -3%.

What is Henan Taloph Pharmaceutical Stock Co Ltd's Operating Income forecast?

Projected CAGR

-4%

For the last 13 years the compound annual growth rate for Henan Taloph Pharmaceutical Stock Co Ltd's operating income is 6%. The projected CAGR for the next 10 years is -4%.

What is Henan Taloph Pharmaceutical Stock Co Ltd's Net Income forecast?

Projected CAGR

-3%

For the last 13 years the compound annual growth rate for Henan Taloph Pharmaceutical Stock Co Ltd's net income is 11%. The projected CAGR for the next 10 years is -3%.